What does PlexBio Co., Ltd. do?

PlexBio Co., Ltd. (6572.TWO) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6572.TWO's market cap?

PlexBio Co., Ltd. (6572.TWO) has a market capitalization of approximately $809.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6572.TWO pay a dividend?

No — PlexBio Co., Ltd. (6572.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6572.TWO profitable?

PlexBio Co., Ltd. (6572.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6572.TWO

PlexBio Co., Ltd.

TWO·Medical, Specialties · Healthcare

NT$7.81NT$0.12+1.56%

Market capNT$809.50M·Aug 26 6:27 AM UTC

Price Chart

NT$7.81+NT$0.12 (+1.56%)today

−61.62%CAGR −17.43%

Select date range

FromTo

Feb 26, 2016Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

6572.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$137.57M

Net Income−NT$38.38M

Net Margin−27.9%

Operating Cash Flow−NT$47.58M

Capital ExpendituresNT$226.00K

Free Cash Flow−NT$47.35M

Return on Equity−13.3%

Return on Invested Capital−7.8%

Net CashNT$277.97M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6572.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6572.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6572.TWO and 80,000+ other tickers.

About PlexBio Co., Ltd.

PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally…

CEO: Ting Cao
Sector: Healthcare
Industry: Medical - Specialties
Exchange: TWO
Employees: 20
Website: www.plexbio.com

Peers

Peers Tab

4188.TWO

AmCad BioMed Corporation

Cap

NT$924.7M

6518.TWO

Concord Medical Co., Ltd.

Cap

NT$1.0B

4192.TWO

SynCore Biotechnology Co.,Ltd

Cap

NT$701.5M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6572.TWO

What does PlexBio Co., Ltd. do?: PlexBio Co., Ltd. (6572.TWO) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6572.TWO's market cap?: PlexBio Co., Ltd. (6572.TWO) has a market capitalization of approximately $809.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6572.TWO pay a dividend?: No — PlexBio Co., Ltd. (6572.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6572.TWO profitable?: PlexBio Co., Ltd. (6572.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.